Pharmacists at the Forefront: Advancing Care for Patients with ROS1+ NSCLC
Episode 4, Oct 15, 07:35 PM
Share
Subscribe
This video explores the evolving treatment landscape for ROS1-positive non-small cell lung cancer (NSCLC), focusing on targeted therapies, clinical evidence for repotrectinib, management of adverse events, and the pharmacist’s role in improving patient care and adherence.